Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance

Sharifa Nasreen, Andrew Calzavara, Sarah A. Buchan, Nisha Thampi, Caitlin Johnson, Sarah E. Wilson, Jeffrey C. Kwong on behalf of the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Ontario investigators
doi: https://doi.org/10.1101/2022.01.12.22269169

Article usage

Article usage: January 2022 to December 2024

AbstractFullPdf
Jan 2022110418313
Feb 20222193121
Mar 2022210855
Apr 2022124246
May 2022130146
Jun 2022104321
Jul 202240010
Aug 202250417
Sep 202245016
Oct 202242016
Nov 202232010
Dec 202226010
Jan 202324018
Feb 202318311
Mar 202322113
Apr 202326212
May 20231214
Jun 2023545
Jul 2023918
Aug 202321148
Sep 20231447
Oct 20231815
Nov 20232342
Dec 20231378
Jan 202410210
Feb 20241946
Mar 20241496
Apr 202411410
May 202411510
Jun 20242258
Jul 20242206
Aug 20241334
Sep 20241336
Oct 20241153
Nov 202413614
Dec 2024434
Back to top
Posted January 16, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance
Sharifa Nasreen, Andrew Calzavara, Sarah A. Buchan, Nisha Thampi, Caitlin Johnson, Sarah E. Wilson, Jeffrey C. Kwong
medRxiv 2022.01.12.22269169; doi: https://doi.org/10.1101/2022.01.12.22269169
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area